Global /China /Healthcare /Medical Devices /603658
chevron_leftBack
Autobio Diagnostics Co., Ltd. logo

Autobio Diagnostics Co., Ltd.

603658
SSE: 603658 Delayed
33.50CNY -1.1%
4.95 USD
As of 15 June 2026, Autobio Diagnostics Co., Ltd. has a market cap of $2.86B USD, ranking #5612 globally and #1228 in China. It ranks #441 in the Healthcare sector, and #93 in the Medical Devices industry.
Global Rank
5612
Country Rank
1228
Sector Rank
441
Industry Rank
93
Key Stats
Market Cap
$2.86BUSD
19.35B CNY
Enterprise Value
$2.74BUSD
18.53B CNY
Revenue (TTM)
$623.18MUSD
4.22B CNY
EBITDA (TTM)
$234.62MUSD
1.59B CNY
Net Income (TTM)
$152.68MUSD
1.03B CNY
EBITDA Margin
38%
Profit Margin
25%
PE Ratio
18.7
Forward PE
17.1
PS Ratio
4.6
PB Ratio
2.1
EV/EBITDA
11.6
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Medical Devices
CEO
Zeng Li Yang open_in_new
Employees
5,773
Founded
1998
Website
autobio.com.cn open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
-1.1% -1.2% 0.4% -9.9% -13% -13%

News

Loading...

Markets

Exchange Ticker Price
Shanghai Stock Exchange
MIC: XSHG
PRIMARY
603658
郑州安图生物工程股份有限公司 Class A
ISIN: CNE100002GC4
Shares Out.:
571.425M1 Shares Float: 252.774M2
TV:
SA:
YF:
GF:
BA:
MS:
33.50 CNY
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Autobio Diagnostics Co., Ltd.

Autobio Diagnostics Co., Ltd. engages in the research and development, production, marketing, sale, and service of clinical diagnostic products in China and internationally. The company offers immunoassay, biochemistry, and microbiology products; reagents and instruments; and technical and support, and training services, as well as engages in biology research and development activities. Its immunoassay products consist of AutoLumo S900 and AutoLumo A1860 that provides user experience for small and medium size labs; AutoLumo A6200/A6600, an automatic immunoassay analyzer; AutoLumo A2000 Plus, an automated chemiluminescence immunoassay analyzer; PHOmo microplate readers; LUmo microplate luminometers; and iWO and iWO-960 microplate washers. The company’s microbiology products include AutoMic-I60 for microbial identification and antibiotic susceptibility testing; AutoStreak S1800, a microbial sample pretreatment system; Autof T series and MALDI-TOF MS system for the identification of pathogenic bacteria; AutoMimo 1200, an instrument for improving pipetting efficiency and optimize workflow in the lab; BC60, an automatic blood culture instrument; and BC120, an automated bacterial culturing and detection. It also provides blood culture bottles and mycoplasma TIES reagents; AutoMolec 1600, an integrated and automated molecular diagnostics analyzer; AutoMolec 3000, an in vitro molecular detection instrument; Ci-120x and Ci-310 benchtop coagulation analyzers; and Autolas Bi 1000, Autolas Bi2600, AutoChem B861, and AutoChem B2000 automated biochemistry analyzers. The company was formerly known as Lifeclone Diagnostics Co., Ltd. and changed its name to Autobio Diagnostics Co., Ltd. in 2003. Autobio Diagnostics Co., Ltd. was founded in 1998 and is headquartered in Zhengzhou, China. Autobio Diagnostics Co., Ltd. operates as a subsidiary of Zhengzhou Autobio Co., Ltd.

Similar Companies

Industry: Medical Devices (China)
Name
Market Cap diff.
PE
$30.06B
203.66B CNY
953%
26.0
$13.61B
92.23B CNY
377%
48.5
$5.61B
38.02B CNY
97%
23.4
$5.52B
37.43B CNY
93%
52.7
688617
$5.04B
34.14B CNY
76%
39.6
$4.55B
30.86B CNY
60%
13.7
Industry: Medical Devices (Global)
Name
Market Cap diff.
PE
$173.27B
6K%
25.8
$160.73B
6K%
56.7
$159.07B
5K%
25.6
DHR
$126.55B
4K%
34.7
SYK
$120.69B
4K%
38.3
MDT
$101.9B
3K%
22.2
chevron_leftBack